Guides to the medication journey.
These guides explain how closed-loop medication management, barcode administration, dose packaging, inpatient dispensing and post-discharge follow-up actually work — the mechanisms, the failure modes, and the cases where the technology is the wrong answer. They are written to be useful whether or not you ever buy anything from OneDose.
Where a guide would normally quote a statistic we cannot attribute to a source, it says so instead. That is a deliberate policy, explained in each guide.
Closed-loop medication management
What is closed-loop medication management?
A definition that survives contact with a pharmacist: what the loop is, what "closed" actually means, and the stage the standard definition leaves out.
How closed-loop medication management works
What confirms what, at each of the seven stages — and the specific question to ask a vendor about each one.
Implementing closed-loop medication management
Sequencing, the costs that get underestimated, the units to start with, and the failure modes that show up in month three rather than week one.
Where medication loops break
The six places a closed loop reopens in practice, why five of them are rational behaviour, and which one is structural.
The five rights of medication administration
What the five rights are, why they were never meant to be a safety system, and what a closed loop adds that a checklist cannot.
Closing the medication loop after discharge
Every guarantee the inpatient loop provides stops at the door. What it would take to extend it, and why nobody has.
Barcode administration and the eMAR
What is barcode medication administration?
How the bedside scan works, what it does and does not verify, and why scan compliance is a weaker signal than it looks.
How to improve BCMA scan rates
Why scan rates plateau, what actually raises them, and how the obvious intervention makes the number better and the ward less safe.
BCMA workarounds
The recurring workarounds, the legitimate pressure behind each one, and why retraining reliably produces better-hidden versions.
What is an eMAR?
The difference between an electronic MAR and a digitised paper one, and why most of the safety benefit comes from what feeds it.
Dose packaging and dispensing formats
What is multi-dose packaging?
Several medications, one package, one administration time. What it solves, what it costs, and the patients it suits badly.
What is unit dose packaging?
One dose, one package, one barcode — the format the hospital medication loop is built on, and why it matters more than it looks.
How does a dose packing machine work?
From verified order to sealed, barcoded package — the mechanism, the verification step most buyers forget to ask about, and what happens when an order changes.
How to choose a dose packing machine
The questions that separate machines, the specs that mislead, and why throughput is almost never the constraint that bites.
Blister packs vs pouches
Two formats for the same job. Which one suits which patient, which is easier to open, and which one your workflow can actually re-pack.
What is automated dose dispensing?
One term, two meanings, and a comparison that goes wrong when a buyer and a vendor are each using a different one.
Inpatient dispensing
What is an automated dispensing cabinet?
What a cabinet is genuinely good at, the safety claim it cannot make, and why override rates are the number that tells you the truth.
Reducing dispensing cabinet overrides
Why overrides happen, why most of them are clinically correct, and how to reduce the ones that are not without moving the behaviour somewhere invisible.
Ward stock vs patient-specific dispensing
The trade between availability and traceability, why every hospital runs both, and how to decide which units get which.
The inpatient medication workflow
From admission medication history to discharge prescription — every handoff in an IPD medication process and what fails at each.
Medication safety
Types of medication errors
A taxonomy by stage rather than by outcome — because where an error started determines what would have caught it.
Reducing medication errors in hospitals
What works, in rough order of effect — and why the two most popular interventions are near the bottom of the list.
Med pass errors in long-term care
Why the med pass is a different problem from hospital administration, and why the fixes that work in a hospital transfer badly.
Wrong-patient medication errors
The error where everything looks normal until afterwards, why human checking fails on it specifically, and the one control that works.
High-alert medication safeguards
Drugs where an ordinary error becomes a serious one, and why the standard safeguard is weaker than most hospitals believe.
Controlled substances, audit and AI governance
Controlled substance diversion prevention
Where diversion actually happens, why detection lags by months, and the controls that shorten the gap.
Narcotic count discrepancies
Most are documentation failures, some are not, and the process for telling them apart is where organisations get this wrong.
Medication administration audit readiness
What a surveyor actually asks for, why reconstruction is the failure mode, and the reports to be able to produce on demand.
Medication reconciliation at discharge
The step that decides what a patient takes for the next year, performed in the busiest ten minutes of their stay.
AI agents in hospital pharmacy
Where agents genuinely take work off a pharmacy, the tasks they must not touch, and the regulatory line that decides which is which.
Post-discharge and continuity of care
How AI reduces 30-day readmissions
The causal chain from a missed dose to a readmission, where AI actually intervenes in it, and what the intervention cannot fix.
Improving medication adherence at 90 days
Adherence does not decay evenly. Why the 90-day mark is where chronic therapy is won or lost, and what actually moves it.
What is continuity-of-care automation?
A definition, the handoffs it covers, and the distinction between automating continuity and automating the clinical decisions inside it.
Transitions of care: the nurse-time problem
Why post-discharge follow-up is rationed, why the rationing is rational, and why that makes it an arithmetic problem rather than a clinical one.
How to cut pharmacy inbound call volume with AI
What is actually in the queue, why IVRs and callbacks do not reduce it, and the difference between deflecting a call and resolving it.
Are AI voice agents HIPAA-compliant?
Compliance is a property of a deployment, not a badge on a product. What HIPAA actually requires of a voice agent, and the questions to ask a vendor.
What clinical questions should a voice agent escalate?
The escalation boundary is the most important design decision in a pharmacy voice agent. Where to draw it, and why it should be drawn conservatively.
Why do these guides have no statistics in them?
Because the numbers you would expect — readmission reduction, adherence lift, share of calls handled — are figures OneDose cannot currently attribute to a named deployment or a published study. Publishing them anyway would make these guides less useful, not more: a statistic without a source is not evidence, it is decoration that happens to have a decimal point.
So each guide argues from mechanism, and where a number genuinely belongs, it says what it cannot tell you and why. When a figure can be attributed, it will appear with the deployment attached.